| Announce Date | 10/28/2025 |
| EPS Normalized Actual | $3.7 (Beat by $0.37) |
| EPS GAAP Actual | $3.7 (Beat by $0.37) |
| Revenue Actual | $5.289B |
| Revenue Surprise | Beat by $5289M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $2.0661 |
| EPS GAAP Estimate | $2.0661 |
| Revenue Estimate | $5.124902002B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 28.57 | 7.18 | 28.02409 | 29.81156 | 1 |
| Dec 2028 | 25.45 | 8.06 | 24.96371 | 26.55598 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.89 | 1.77803 | 5.289B | 3.16% | 86.93M |
| FQ2 2025 (Jun 2025) | 3.16 | 3.16 | 5.271B | 3.19% | 5271M |
| FQ1 2025 (Mar 2025) | 4.31 | 4.31 | 5.223B | -2.78% | 5223M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 5.072B | -6.05% | 5072M |
| FQ3 2024 (Sep 2024) | 7.12 | 7.12 | 5.122B | 1.09% | 5122M |
| FQ2 2024 (Jun 2024) | 2.66 | 2.66 | 5.103B | 0.41% | 5103M |
| FQ1 2024 (Mar 2024) | 21.6 | 21.6 | 5.368B | 6.46% | 5368M |
| FQ4 2023 (Dec 2023) | 0.0078 | 0.0078 | 5.379B | 7.23% | 5379M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
2.0661
Consensus Revenue Estimates
5.124902002B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.91 | -- | 3.70254 | 4.23983 | 4 |
| FQ3 2027 (Sep 2027) | 3.47 | -- | 3.28589 | 3.76272 | 3 |
| FQ2 2027 (Jun 2027) | 3.29 | -- | 3.11544 | 3.56753 | 4 |
| FQ1 2027 (Mar 2027) | 3.64 | -- | 3.44687 | 3.94706 | 3 |
| FQ4 2026 (Oct 2026) | 2.17697 | -- | 2.13105 | 2.22289 | 3 |
| FQ3 2026 (Jul 2026) | 2.1524 | -80.73 | 2.10699 | 2.19781 | 4 |
| FQ2 2026 (Jun 2026) | 1.94002 | -62.88 | 1.91439 | 1.96052 | 4 |
| FQ1 2026 (Mar 2026) | 1.87751 | -129.56 | 1.85271 | 1.89735 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 6.01B | -- | 5.76B | 6.4B | 5 |
| FQ3 2027 (Sep 2027) | 5.76B | -- | 5.52B | 6.13B | 4 |
| FQ2 2027 (Jun 2027) | 5.79B | -- | 5.56B | 6.17B | 5 |
| FQ1 2027 (Mar 2027) | 5.66B | -- | 5.43B | 6.03B | 4 |
| FQ4 2026 (Oct 2026) | 5.36B | -- | 5.28B | 5.45B | 4 |
| FQ3 2026 (Jul 2026) | 5.47B | 3.3 | 5.38B | 5.56B | 5 |
| FQ2 2026 (Jun 2026) | 5.47B | 3.58 | 5.41B | 5.51B | 5 |
| FQ1 2026 (Mar 2026) | 5.46B | 4.36 | 5.41B | 5.51B | 6 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
0
EPS # of in-lines
1
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2.11197 | 3.89 | 1.77803 | 45.71% |
| FQ2 2025 (Jun 2025) | 3.16 | 3.16 | 100% | |
| FQ1 2025 (Mar 2025) | 4.31 | 4.31 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 7.12 | 7.12 | 100% | |
| FQ2 2024 (Jun 2024) | 2.66 | 2.66 | 100% | |
| FQ1 2024 (Mar 2024) | 21.6 | 21.6 | 100% | |
| FQ4 2023 (Dec 2023) | 0.0078 | 0.0078 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $5.2B | $5.29B | $86.93M | 1.64% |
| FQ2 2025 (Jun 2025) | $0B | $5.27B | $5271M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $5.22B | $5223M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $5.07B | $5072M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $5.12B | $5122M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $5.1B | $5103M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $5.37B | $5368M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $5.38B | $5379M | 100% |